Home › Research › Long-term cohort studies
Diabetes and hypertension are related to amyloid-beta burden in the population-based Rotterdam Study
van Arendonk J, Neitzel J, Steketee RME, van Assema DME, Vrooman HA, Segbers M, Ikram MA, Vernooij MW.. Brain : a journal of neurology, 2023-01-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Higher vascular disease burden increases the likelihood of developing dementia, including Alzheimer's disease. Better understanding the association between vascular risk factors and Alzheimer's disease pathology at the predementia stage is critical for developing effective strategies to delay cognitive decline. In this work, we estimated the impact of six vascular risk factors on the presence and severity of in vivo measured brain amyloid-beta (Aβ) plaques in participants from the population-based Rotterdam Study.
What this study adds
Evidence grade: Low
This study found that diabetes and hypertension were related to amyloid-beta burden in the brain before dementia in a population-based cohort. Reported effect size: 51.2%; 29.9%; 12.8%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
van Arendonk, J., Neitzel, J., Steketee, R. M. E., van Assema, D. M. E., Vrooman, H. A., Segbers, M., et al. (2023). Diabetes and hypertension are related to amyloid-beta burden in the population-based Rotterdam Study. Brain : a journal of neurology. https://doi.org/10.1093/brain/awac354
Vancouver
van Arendonk J, Neitzel J, Steketee RME, van Assema DME, Vrooman HA, Segbers M, et al. Diabetes and hypertension are related to amyloid-beta burden in the population-based Rotterdam Study. Brain : a journal of neurology. 2023. doi:10.1093/brain/awac354. PMID: 36374264.
BibTeX
@article{vanarendonk2023-36374264,
author = {van Arendonk, J. and Neitzel, J. and Steketee, R. M. E. and van Assema, D. M. E. and Vrooman, H. A. and Segbers, M. and Ikram, M. A. and Vernooij, M. W.},
title = {{Diabetes and hypertension are related to amyloid-beta burden in the population-based Rotterdam Study}},
journal = {Brain : a journal of neurology},
year = {2023},
doi = {10.1093/brain/awac354},
pmid = {36374264},
url = {https://doi.org/10.1093/brain/awac354}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Better understanding the association between vascular risk factors and Alzheimer's disease pathology at the predementia stage is critical for developing effective strategies to delay cognitive decline.
- In this work, we estimated the impact of six vascular risk factors on the presence and severity of in vivo measured brain amyloid-beta (Aβ) plaques in participants from the population-based Rotterdam Study.
- Vascular risk factors (hypertension, hypercholesterolaemia, diabetes, obesity, physical inactivity and smoking) were assessed 13 (2004-2008) and 7 years (2009-2014) prior to 18F-florbetaben PET (2018-2021) in 635 dementia-free participants.
- Vascular risk factors were associated with binary amyloid PET status or continuous PET readouts (standard uptake value ratios, SUVrs) using logistic and linear regression models, respectively, adjusted for age, sex, education, APOE4 risk allele count and time between vascular risk and PET assessment.
Why it matters
This study found that diabetes and hypertension were related to amyloid-beta burden in the brain before dementia in a population-based cohort. It reports associations and does not show that treating these conditions prevents or cures Alzheimer's disease.
Study details
- Effect size51.2%; 29.9%; 12.8%
- Evidence strengthLow
How this study scored 57/100
Published in a leading specialty journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Brain : a journal of neurology) |
| Journal's citation record | 4 / 4 | Brain: journal h-index 503 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2023 — within 6 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 82 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 16.4 citations a year over 5 year(s) since 2023 |
| Impact for its field and year | 4 / 6 | Cited 9.5× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 3 / 6 | Cited by 10 other studies in this library |
| Still being cited | 3 / 4 | Cited 69 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Meike Willemijn Vernooij: h-index 99 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | Harvard University: institution h-index 3,235 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 36374264) |
| Free to read | 2 / 2 | Free to read |
| Total | 57 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 24.
Later studies that cite this one
10 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Long-term cohort studies from nearby years
Also tagged “precursor”
1,337 studies in the library carry the topic tag “precursor”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,337 tagged studies.